On 1 February 2019, the World Trade Organization (WTO) published a submission (IP/C/W/651) by South Africa to the TRIPS Council on Intellectual Property and the Public Interest: Promoting Public Health Through Competition Law and Policy. The South African paper endeavors… Continue Reading
Here you will find the daily calendars of Deputy USTR Robert W. Holleyman II from 2014 to 2016. These schedules were obtained by KEI via FOIA request to USTR. Note: The 2016 calendar ends July 13, 2016, the file date… Continue Reading
Here you will find the daily calendars of Deputy USTR Michael Punke from 2013 to 2016. These schedules were obtained by KEI via FOIA request to USTR. Note: The 2016 calendar ends July 13, 2016, the file date of the… Continue Reading
This October 11, 2017 email, from Catherine Robinson of Pfizer to Daniel Watson and John Meile of USTR, asks USTR to block a competitor from a tender to sell a drug. USTR provides one email and redacts details including the… Continue Reading
KEI has received Pfizer and USTR emails and a Pfizer briefing memo to USTR from September 2017, asking the USTR to block a Malaysia Requirement to disclose drug prices. The documents were obtained under a Freedom of Information request to… Continue Reading
The attached document is a 78 page PDF file obtained from USTR under the Freedom of Information Act (copy here), regarding communications between Gilead and USTR, over Malaysia’s decision to grant a compulsory license on patents for HCV treatments. This… Continue Reading
The following are copies of or links to USTR’s National Trade Estimate Report on Foreign Trade Barriers, typically referred to as the annual NTE reports. PDF versions, 2004 to 2018. 2018NTE Comments from Regulations.Gov, notice August 2017 2017NTE Comments from… Continue Reading
In March 2018, the Office of the United States Trade Representative (USTR) published its 2018 National Trade Estimate Report on Foreign Trade Barriers (NTE). Every year, the USTR is mandated to “submit to the President,the Senate Finance Committee, and appropriate… Continue Reading
FOR IMMEDIATE RELEASE March 20, 2018 kim.treanor@keionline.org (202)-332-2670 A broad international coalition of over 30 human rights organizations, including some across the United States and Latin America, have come together to ensure that providing access to health care doesn’t come… Continue Reading
These were KEI comments to USTR regarding PhRMA’s efforts to target Malaysia as a Priority Foreign Country for issuing a compulsory license on sofosbuvir patents. Malaysia.14March2018.KEI.USTR.Special 301 March 14, 2018 The Honorable Robert Lighthizer United States Trade Representative Executive Office… Continue Reading